Novodiag RESP-4
Let the assistant research this device
The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.
Free to try · every answer cites its records
Basic Information
- Primary DI
- 06430041761525
- Basic UDI-DI Code
- B-06430041761525
- Reference
- Novodiag RESP-4
- Device Types
-
Single use
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- No Longer On The Market
- Manufacturer
- Mobidiag Ltd.
Additional Description
The Novodiag® RESP-4 test is a molecular random-access test, easy to use that aids in the detection and differentiation of RNA from SARS-CoV-2, influenza A and B and RSV A/B viruses. The test includes two SARS-CoV-2 specific gene targets and reports them separately to eliminate false negative results due to potential target mutations. The test detects also clinically associated influenza A subtypes and clades of A(H1N1), A(H3N2), and A(H5N1), and their variants as well as two influenza B lineages: B/Yamagata and B/Victoria and RSVA and B.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0105070503 | RESPIRATORY TRACT INFECTIONS - MULTIPLEX NA REAGENTS |
Available In Countries
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).